Epizyme, Inc
EPZM
EPZM was delisted on the 11th of August, 2022.
134 hedge funds and large institutions have $1B invested in Epizyme, Inc in 2019 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 52 increasing their positions, 28 reducing their positions, and 22 closing their positions.
86% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 28
80% more funds holding in top 10
Funds holding in top 10: 5 → 9 (+4)
68% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 22
11% more funds holding
Funds holding: 121 → 134 (+13)
4% more capital invested
Capital invested by funds: $965M → $1B (+$36.8M)
67% less call options, than puts
Call options by funds: $687K | Put options by funds: $2.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$21M |
| 2 |
BlackRock
New York
|
+$20M |
| 3 |
CCM
Consonance Capital Management
New York
|
+$16.5M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$13.3M |
| 5 |
State Street
Boston,
Massachusetts
|
+$10.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$32.2M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$26.9M |
| 3 |
Millennium Management
New York
|
-$13M |
| 4 |
Jennison Associates
New York
|
-$8.8M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
-$4.9M |
EPZM Hedge Fund Activity: Q2 2019 in Review
134 of the 4,625 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q2 2019, worth a combined $1B — up 3.8% from $965M a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new EPZM positions and 22 closed out — a net gain of 15 holders — while 52 added to existing stakes and 28 trimmed.
The largest buyer was Vanguard Group, adding an estimated $21M. The largest seller was NEA Management Company, cutting an estimated $32.2M.
- 134 institutional investors held Epizyme, Inc (EPZM) as of Q2 2019, up from 121 in Q1 2019.
- Funds reported $1B of Epizyme, Inc stock for Q2 2019, up 3.8% quarter-over-quarter.
- 37 funds opened new Epizyme, Inc positions in Q2 2019 and 22 closed out, a net change of +15 holders.
- The largest Epizyme, Inc buyer in Q2 2019 was Vanguard Group, an estimated $21M added.
- The largest Epizyme, Inc seller in Q2 2019 was NEA Management Company, an estimated $32.2M sold.
Based on aggregated 13F filings for Q2 2019.